Acute promyelocytic leukemia during pregnancy: A systematic analysis of outcome

Vivek Verma, Smith Giri, Samyak Manandhar, Ranjan Pathak, Vijaya R Bhatt

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The outcomes of acute promyelocytic leukemia (APL) in pregnancy are largely unknown. The MEDLINE database was systematically searched to obtain 43 articles with 71 patients with new-onset APL during pregnancy. Induction therapy included various regimens of all-trans retinoic acid (ATRA), cytarabine, and anthracycline and resulted in a complete remission rate of 93%. Obstetric and fetal complications included pre-term deliveries (46%), spontaneous/therapeutic abortion/intrauterine death (33.3%) and other neonatal complications (25.9%). Mothers diagnosed in the first trimester were more likely to experience obstetric (p < 0.01) and fetal (p < 0.01) complications. To our knowledge, this is the largest systematic review of APL in pregnancy. The vast majority of APL patients in pregnancy may achieve remission with initial induction therapy. APL or its therapy in pregnancy, however, is associated with a high risk of fetal and obstetrical complications. The results of our study may help in patient counseling and informed decision-making.

Original languageEnglish (US)
Pages (from-to)616-622
Number of pages7
JournalLeukemia and Lymphoma
Volume57
Issue number3
DOIs
StatePublished - Mar 3 2016

Fingerprint

Acute Promyelocytic Leukemia
Pregnancy
Obstetrics
Therapeutic Abortion
Anthracyclines
Cytarabine
Spontaneous Abortion
First Pregnancy Trimester
Tretinoin
MEDLINE
Counseling
Decision Making
Therapeutics
Mothers
Databases

Keywords

  • Acute myeloid leukemia
  • Acute promyelocytic leukemia
  • All-trans retinoic acid
  • Anthracycline
  • Pregnancy

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Acute promyelocytic leukemia during pregnancy : A systematic analysis of outcome. / Verma, Vivek; Giri, Smith; Manandhar, Samyak; Pathak, Ranjan; Bhatt, Vijaya R.

In: Leukemia and Lymphoma, Vol. 57, No. 3, 03.03.2016, p. 616-622.

Research output: Contribution to journalArticle

Verma, Vivek ; Giri, Smith ; Manandhar, Samyak ; Pathak, Ranjan ; Bhatt, Vijaya R. / Acute promyelocytic leukemia during pregnancy : A systematic analysis of outcome. In: Leukemia and Lymphoma. 2016 ; Vol. 57, No. 3. pp. 616-622.
@article{f51d0406edb547618b4b2dabcba2f44f,
title = "Acute promyelocytic leukemia during pregnancy: A systematic analysis of outcome",
abstract = "The outcomes of acute promyelocytic leukemia (APL) in pregnancy are largely unknown. The MEDLINE database was systematically searched to obtain 43 articles with 71 patients with new-onset APL during pregnancy. Induction therapy included various regimens of all-trans retinoic acid (ATRA), cytarabine, and anthracycline and resulted in a complete remission rate of 93{\%}. Obstetric and fetal complications included pre-term deliveries (46{\%}), spontaneous/therapeutic abortion/intrauterine death (33.3{\%}) and other neonatal complications (25.9{\%}). Mothers diagnosed in the first trimester were more likely to experience obstetric (p < 0.01) and fetal (p < 0.01) complications. To our knowledge, this is the largest systematic review of APL in pregnancy. The vast majority of APL patients in pregnancy may achieve remission with initial induction therapy. APL or its therapy in pregnancy, however, is associated with a high risk of fetal and obstetrical complications. The results of our study may help in patient counseling and informed decision-making.",
keywords = "Acute myeloid leukemia, Acute promyelocytic leukemia, All-trans retinoic acid, Anthracycline, Pregnancy",
author = "Vivek Verma and Smith Giri and Samyak Manandhar and Ranjan Pathak and Bhatt, {Vijaya R}",
year = "2016",
month = "3",
day = "3",
doi = "10.3109/10428194.2015.1065977",
language = "English (US)",
volume = "57",
pages = "616--622",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Acute promyelocytic leukemia during pregnancy

T2 - A systematic analysis of outcome

AU - Verma, Vivek

AU - Giri, Smith

AU - Manandhar, Samyak

AU - Pathak, Ranjan

AU - Bhatt, Vijaya R

PY - 2016/3/3

Y1 - 2016/3/3

N2 - The outcomes of acute promyelocytic leukemia (APL) in pregnancy are largely unknown. The MEDLINE database was systematically searched to obtain 43 articles with 71 patients with new-onset APL during pregnancy. Induction therapy included various regimens of all-trans retinoic acid (ATRA), cytarabine, and anthracycline and resulted in a complete remission rate of 93%. Obstetric and fetal complications included pre-term deliveries (46%), spontaneous/therapeutic abortion/intrauterine death (33.3%) and other neonatal complications (25.9%). Mothers diagnosed in the first trimester were more likely to experience obstetric (p < 0.01) and fetal (p < 0.01) complications. To our knowledge, this is the largest systematic review of APL in pregnancy. The vast majority of APL patients in pregnancy may achieve remission with initial induction therapy. APL or its therapy in pregnancy, however, is associated with a high risk of fetal and obstetrical complications. The results of our study may help in patient counseling and informed decision-making.

AB - The outcomes of acute promyelocytic leukemia (APL) in pregnancy are largely unknown. The MEDLINE database was systematically searched to obtain 43 articles with 71 patients with new-onset APL during pregnancy. Induction therapy included various regimens of all-trans retinoic acid (ATRA), cytarabine, and anthracycline and resulted in a complete remission rate of 93%. Obstetric and fetal complications included pre-term deliveries (46%), spontaneous/therapeutic abortion/intrauterine death (33.3%) and other neonatal complications (25.9%). Mothers diagnosed in the first trimester were more likely to experience obstetric (p < 0.01) and fetal (p < 0.01) complications. To our knowledge, this is the largest systematic review of APL in pregnancy. The vast majority of APL patients in pregnancy may achieve remission with initial induction therapy. APL or its therapy in pregnancy, however, is associated with a high risk of fetal and obstetrical complications. The results of our study may help in patient counseling and informed decision-making.

KW - Acute myeloid leukemia

KW - Acute promyelocytic leukemia

KW - All-trans retinoic acid

KW - Anthracycline

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=84939175681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939175681&partnerID=8YFLogxK

U2 - 10.3109/10428194.2015.1065977

DO - 10.3109/10428194.2015.1065977

M3 - Article

C2 - 26110880

AN - SCOPUS:84939175681

VL - 57

SP - 616

EP - 622

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 3

ER -